symbicort turbuhaler forte 400 mikrogramov/12 mikrogramov/inhalácia
astrazeneca ab, Švédsko - formoterol a budezonid - 14 - bronchodilatantia, antiasthmatica
olynth ha 0,05 %
mcneil healthcare (ireland) limited, Írsko - xylometazolín - 69 - otorhinolaryngologica
olynth ha 0,1 %
mcneil healthcare (ireland) limited, Írsko - xylometazolín - 69 - otorhinolaryngologica
spiriva respimat
boehringer ingelheim international gmbh, nemecko - tiotropiumbromid - 14 - bronchodilatantia, antiasthmatica
formoterol cipla 12 mikrogramov
cipla europe nv - formoterol - 14 - bronchodilatantia, antiasthmatica
airbufo forspiro 320 mikrogramov/ 9 mikrogramov/dávka
sandoz pharmaceuticals d.d., slovinsko - formoterol a budezonid - 14 - bronchodilatantia, antiasthmatica
biresp spiromax
teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - drogy obštrukčnej choroby dýchacích ciest, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).
bretaris genuair
covis pharma europe b.v. - aclidinium bromide - pľúcna choroba, chronická obštrukcia - drogy obštrukčnej choroby dýchacích ciest, - bretaris genuair je indikovaný ako udržiavacia bronchodilatačná liečba na zmiernenie symptómov u dospelých pacientov s chronickou obštrukčnou chorobou pľúc (copd).
duoresp spiromax
teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - drogy obštrukčnej choroby dýchacích ciest, - asthma duoresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdduoresp spiromax is indicated in adults, aged 18 years and older for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).
eklira genuair
covis pharma europe b.v. - aclidinium bromide - pľúcna choroba, chronická obštrukcia - drogy obštrukčnej choroby dýchacích ciest, - eklira genuair je indikovaná ako udržiavacia bronchodilatačná liečba na zmiernenie príznakov u dospelých pacientov s chronickou obštrukčnou chorobou pľúc (copd).